Celestial Biolabs Limited - Board Meeting Intimation for To Consider The Standalone & Consolidated Audited Financial Results For The Year Ended 31.03.2023 And Standalone & Consolidated Unaudited Financial Results For The Q1, Q2 & Q3 Of FY Year 2023-24

Celestial Biolabs Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/03/2024 ,inter alia, to consider and approve Pursuant to Regulation 29(1)(a) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 this is to intimate you that a meeting of the Board of Directors and Audit Committee of the Company is schedule to be held on 29.03.2024: 1) to consider and take on record the standalone audited financial results & consolidated audited financial results of the Company for the quarter / year ended 31.03.2023; 2) to consider and take on record the standalone unaudited financial results & consolidated unaudited financial results of the Company for the quarter / 3 months ended 30.06.2023; 3) to consider and take on record the standalone unaudited financial results & consolidated unaudited financial results of the Company for the quarter / half year ended 30.09.2023; 4)to consider and take on record the standalone unaudited financial results & consolidated unaudited financial results of the Company for the quarter / nine months ended 31.12.2023